13D Filing: Gilead Capital LP and Landauer Inc (LDR)

The following constitutes
Amendment No. 5 to the Schedule 13D filed by the undersigned (“Amendment No. 5”). This Amendment No. 5 amends the Schedule
13D as specifically set forth herein.

Item 4.

Purpose of Transaction.

Item 4 is hereby amended
to add the following:

As previously disclosed,
the Reporting Persons entered into a tender and support agreement with Fortive Corporation and Fern Merger Sub Inc. (“Sub”),
pursuant to which the Reporting Persons agreed to tender all of the Shares they beneficially owned into the tender offer commenced
by Sub. On October 19, 2017, the tender offer closed and Sub accepted for purchase all of the Shares tendered by the Reporting
Persons.

Item 5.

Interest in Securities of the Issuer.

Item 5 is hereby amended
and restated to read as follows:

(a)-(b) Effective
October 19, 2017, the Reporting Persons tender all of the Shares they beneficially owned into the tender offer commenced by Sub.
Accordingly, the Reporting Persons no longer beneficially own any Shares of the Issuer.

(c) Other than tendering
all 525,361 Shares beneficially owned by the Reporting Persons into the tender offer at a purchase price of $67.25 per share, as
further described in Item 4, the Reporting Persons have not entered into any transactions in the Shares since the filing of Amendment
No. 4.

(d) Not applicable.

(e) As of the close
of business on October 19, 2017, the Reporting Persons ceased to be the beneficial owners of more than 5% of the Shares of the
Issuer.